Author

Peluso M

University of California, San Francisco - Cited by 5,847

Biography

He is  an infectious disease clinical-translational physician-scientist. His primary interests are HIV and COVID-19. he nvolved with clinical and laboratory research aimed at understanding the HIV reservoir and implementing clinical trials to disrupt the reservoir with the aim of inducing antiretroviral therapy-free HIV remission. In addition, he  manage a large observational study of people who previously had SARS-CoV-2 infection with the goal of understanding the long-term biological and immunological consequences of COVID-19.
Title
Cited by
Year
Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: a systematic review and meta-analysis
MS Durstenfeld, K Sun, P Tahir, MJ Peluso, SG Deeks, MA Aras, ...JAMA network open 5 (10), e2236057-e2236057, 2022202
38
2022
Chronic viral coinfections differentially affect the likelihood of developing long COVID
MJ Peluso, TM Deveau, SE Munter, D Ryder, A Buck, G Beck-Engeser, ...The Journal of Clinical Investigation 133 (3), 2023202
29
2023
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection
MJ Peluso, MA Spinelli, TM Deveau, CA Forman, SE Munter, S Mathur, ...Aids 36 (12), F7-F16, 2022202
28
2022
Infectious viral shedding of SARS-CoV-2 Delta following vaccination: a longitudinal cohort study
M Garcia-Knight, K Anglin, M Tassetto, S Lu, A Zhang, SA Goldberg, ...PLoS Pathogens 18 (9), e1010802, 2022202
16
2022
Plasma markers of neurologic injury and inflammation in people with self-reported neurologic postacute sequelae of SARS-CoV-2 infection
MJ Peluso, HM Sans, CA Forman, AN Nylander, H Ho, S Lu, SA Goldberg, ...Neurology-Neuroimmunology Neuroinflammation 9 (5), 2022202
16
2022
Factors associated with long COVID symptoms in an online cohort study
MS Durstenfeld, MJ Peluso, ND Peyser, F Lin, SJ Knight, A Djibo, ...Open forum infectious diseases 10 (2), ofad047, 2023202
11
2023
Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA. 1 Sublineage Compared with Pre-Omicron Variant Specimens—San Francisco Bay Area, California …
M Tassetto, M Garcia-Knight, K Anglin, S Lu, A Zhang, M Romero, ...Morbidity and Mortality Weekly Report 71 (36), 1151, 2022202
10
2022
Low prevalence of interferon α autoantibodies in people experiencing symptoms of post–coronavirus disease 2019 (COVID-19) conditions, or long COVID
MJ Peluso, A Mitchell, CY Wang, S Takahashi, R Hoh, V Tai, ...The Journal of infectious diseases 227 (2), 246-250, 2023202
10
2023
Development of a definition of postacute sequelae of SARS-CoV-2 infection
T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ...Jama 329 (22), 1934-1946, 2023202
8
2023
Magnitude and determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) household transmission: a longitudinal cohort study
JD Kelly, S Lu, K Anglin, M Garcia-Knight, J Pineda-Ramirez, ...Clinical Infectious Diseases 75 (Supplement_2), S193-S204, 20228202
8
2022
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy
X Lian, KW Seiger, EM Parsons, C Gao, W Sun, GT Gladkov, IC Roseto, ...Cell Host & Microbe 31 (1), 83-9. e5, 2023202
6
2023
Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2
K Yin, MJ Peluso, R Thomas, MG Shin, J Neidleman, X Luo, R Hoh, ...bioRxiv, 2023.02. 09.27892, 2023202
5
2023
Evaluation of severe acute respiratory syndrome coronavirus 2 nucleocapsid antigen in the blood as a diagnostic test for infection and infectious viral shedding
S Mathur, MC Davidson, K Anglin, S Lu, SA Goldberg, M Garcia-Knight, ...Open Forum Infectious Diseases 9 (11), ofac56, 2022202
3
2022
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients
A Bodansky, CY Wang, A Saxena, A Mitchell, S Takahashi, K Anglin, ...medRxiv, 03.0. 06.38553, 030
2
2023
Critical considerations for public engagement in stem cell-related research
J Sugarman, A Clark, J Fishkin, K Kato, K McCormack, M Munsie, ...Stem Cell Reports 18 (), 40-46, 030
2
2023
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
H Bonilla, MJ Peluso, K Rodgers, JA Aberg, TF Patterson, R Tamburro, ...Frontiers in immunology 14, 119459, 030
2
2023
Association of Nirmatrelvir/Ritonavir Treatment with Long COVID Symptoms in an Online Cohort of Non-Hospitalized Individuals Experiencing Breakthrough SARS-CoV-2 Infection in …
MS Durstenfeld, MJ Peluso, F Lin, ND Peyser, C Isasi, TW Carton, ...medRxiv, 2023.03. 02.23286730, 2023202
1
2023
Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States
K Dubé, J Kanazawa, H Patel, M Louella, L Sylla, J Sheehy, L Dee, ...BMC Medical Ethics 23 (), -7, 2022202
1
2022
SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency
S Takahashi, MJ Peluso, J Hakim, K Turcios, O Janson, I Routledge, ...American Journal of Epidemiology, kwad06, 2023202
1
2023
Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019
Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 209MS Durstenfeld, MJ Peluso, P Kaveti, C Hill, D Li, E Sander, ...The Journal of Infectious Diseases, jiad3, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=vejnOn8AAAAJ&hl=en

Cited by
Citations 5847
h-index 30
i10-index 68
Recommended Journals
Open Access Journals